Quick Takeaways
- FGMK Business Holdings, LLC filed SCHEDULE 13G for MAIA Biotechnology, Inc. Common Stock, par value $0.0001 per share (MAIA).
- Disclosed ownership: 10%.
- Date of event: 14 Sep 2024.
FGMK Business Holdings, LLC - 14 Sep 2024 SCHEDULE 13G Report for MAIA Biotechnology, Inc. Common Stock, par value $0.0001 per share (MAIA)
- Filing Manager
- FGMK Business Holdings, LLC
- Reporting Manager
- FGMK Business Holdings, LLC
- Symbol
- MAIA
- Shares outstanding
- 28,924,535 shares
- Disclosed Ownership
- 2,889,561 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 03 Mar 2025, 17:28:34 UTC
- Date of event
- 14 Sep 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"FGMK Business Holdings, LLC disclosed 10% ownership in MAIA Biotechnology, Inc. Common Stock, par value $0.0001 per share (MAIA) on 14 Sep 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Mar 2025, 17:28.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| FGMK Business Holdings, LLC | 10% | 2,889,561 | 2,861,113 | 0 | /s/ Michael Fernandez | Michael Fernandez, Attorney in Fact | |
| FGMK, LLC | 10% | 2,889,561 | 28,448 | 0 | /s/ Michael Fernandez | Michael Fernandez, Attorney in Fact |